News: News
Interdisciplinary Stem Cell Institute Selected for National Cell Therapy Research Network
The University of Miami Miller School of Medicine's Interdisciplinary Stem Cell Institute (ISCI) has been selected as one of seven U.S. centers of excellence to participate in the Cardiovascular Cell Therapy Research Network (CCTRN), a national network funded by the National Institutes of Health's National Heart, Lung and Blood Institute (NHLBI).
UM Researchers Identify New Gene Causing Blindness
Researchers led by geneticists at the University of Miami Miller School of Medicine have identified a new gene that causes retinitis pigmentosa, a form of blindness, ending one South Florida family's nearly 20-year search for what caused three of their four children to lose their sight.
Study Links Treatment to Prevent HIV Transmission to Newborns to Cardiac Problems
The use of antiretroviral therapy (ART) in HIV-positive pregnant women reduces the chance of HIV transmission to the unborn child, but a newly published study by University of Miami Miller School of Medicine pediatric researchers and others is raising questions about the cardiac effects of that treatment. The findings are published in the December 28 issue of the Journal of the American College of Cardiology.
Breast Cancer Physician Named “Outstanding Hispanic”
A Miller School physician known for his passion in the fight against breast cancer has been honored for that work and much more on a national stage. Orlando E. Silva, M.D., J.D., associate professor of medicine and faculty member of the Jay Weiss Center for Social Medicine and Health Equity, was chosen to receive the "Outstanding Hispanic Award" at The Americano's First Annual Hispanic Forum, held in Washington, D.C.
Miller School Receives Highest Grade for Conflict of Interest Policy
The Miller School has become the first medical school in the state to receive an ‘A’ grade from the American Medical Student Association (AMSA) for its conflict of interest policies regarding interaction between students or faculty and the pharmaceutical industry, improving one letter grade from last year.
Read more about the Miller School's conflict of interest policy »